Calcium ions and osteoclastogenesis initiate the induction of bone formation by coral-derived macroporous constructs

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 11, 2013, Pages 1444-1457

  Klar, Roland M ^a   Duarte, Raquel ^a   Dix Peek, Therese ^a   Dickens, Caroline ^a   Ferretti, Carlo ^a   Ripamonti, Ugo ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Ca++; Calcium channel blocker verapamil hydrochloride; Functionalized nano patterned topographies; Osteoclast inhibitor biphosphonate zoledronate; qRT PCR

Indexed keywords

ANTHOZOA; GONIOPORA; PAPIO; PAPIO URSINUS;

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CARRIER PROTEIN; COLLAGEN TYPE 4; HYDROXYAPATITE; NOGGIN PROTEIN; VERAPAMIL;

ANIMAL; ANTHOZOA; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; CALCIUM CHANNEL BLOCKER VERAPAMIL HYDROCHLORIDE; CHEMISTRY; DRUG EFFECT; FUNCTIONALIZED NANO-PATTERNED TOPOGRAPHIES; METABOLISM; OSTEOCLAST; OSTEOCLAST INHIBITOR BIPHOSPHONATE ZOLEDRONATE; PAPIO URSINUS; PHYSIOLOGY; POROSITY; PROSTHESES AND ORTHOSES; QRT-PCR;

CA++; CALCIUM CHANNEL BLOCKER VERAPAMIL HYDROCHLORIDE; FUNCTIONALIZED NANO-PATTERNED TOPOGRAPHIES; OSTEOCLAST INHIBITOR BIPHOSPHONATE ZOLEDRONATE; QRT-PCR;

ANIMALS; ANTHOZOA; BONE DENSITY CONSERVATION AGENTS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONE SUBSTITUTES; CALCIUM; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKERS; CARRIER PROTEINS; COLLAGEN TYPE IV; DIPHOSPHONATES; DURAPATITE; OSTEOCLASTS; PAPIO URSINUS; POROSITY; PROSTHESES AND IMPLANTS; VERAPAMIL;

EID: 84891165607     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12125     Document Type: Article

References (73)

1. Williams D. The continuing evolution of biomaterials. Biomaterials. 2011; 32: 1-2.
2. Ripamonti U, Duneas N. Tissue engineering of bone by osteoinductive biomaterials. MRS Bull. 1996; 21: 36-9.
3. Ripamonti U, van den Heever B, van Wyk J. Expression of the osteogenic phenotype in porous hydroxyapatite implanted extraskeletally in baboons. Matrix. 1993; 13: 491-502.
4. Ripamonti U, Crooks J, Kirkbride AN. Sintered porous hydroxyapatites with intrinsic osteoinductive activity: geometric induction of bone formation. S Afr J Sci. 1999; 95: 335-43.
5. Ripamonti U. Soluble, insoluble and geometric signals sculpt the architecture of mineralized tissues. J Cell Mol Med. 2004; 8: 169-80.
6. Ripamonti U, Richter PW, Thomas ME. Self-inducing shape memory geometric cues embedded within smart hydroxyapatite-based biomimetic matrices. Plast Reconstr Surg. 2007; 120: 1796-807.
7. Buxboim A, Ivanovska IL, Discher DE. Matrix elasticity, cytoskeletal forces and physics of the nucleus: how deeply do cells 'feel' outside and in? J Cell Sci. 2010; 123: 297-308.
8. Fu J, Wang YK, Yang MT, et al. Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat Methods. 2010; 7: 733-6.
9. Vlacic-Zischke J, Hamlet SM, Friis T, et al. The influence of surface microroughness and hydrophilicity of titanium on the up-regulation of TGFβ/BMP signalling in osteoblasts. Biomaterials. 2011; 32: 665-71.
10. McNamara LE, Sjöström T, Burgess KE, et al. Skeletal stem cell physiology on functionally distinct titania nanotopographies. Biomaterials. 2011; 32: 7403-10.
11. Watari S, Hayashi K, Wood JA, et al. Modulation of osteogenic differentiation in hMSCs cells by submicron topographically-patterned ridges and grooves. Biomaterials. 2012; 33: 128-36.
12. Ripamonti U. The concavity: the 'shape of life and the control of bone differentiation. Available at http://www.scienceinafrica.co.za/2012/ripamonti_bone.htm (accessed 7 May 2012).
13. Ripamonti U. Inductive bone matrix and porous hydroxyapatite composites in rodents and non-human primates. In: Yamamuro T, Wilson-Hench J, Hench LL, editors. The handbook of bioactive ceramics, volume II: calcium phosphate and hydroxylapatite ceramics. Florida: CRC Press; 1990. pp. 245-53.
14. Ripamonti U. The morphogenesis of bone in replicas of porous hydroxyapatite obtained from conversion of calcium carbonate exoskeletons of coral. J Bone Joint Surg Am. 1991; 73: 692-703.
15. Reddi AH. Symbiosis of biotechnology and biomaterials: applications in tissue engineering of bone and cartilage. J Cell Biochem. 1994; 56: 192-5.
16. Ripamonti U, Reddi AH. Bone morphogenetic proteins: applications in plastic and reconstructive surgery. Adv Plast Reconstr Surg. 1995; 11: 47-65.
17. Reddi AH. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng. 2000; 6: 351-9.
18. Ripamonti U, Ramoshebi LN, Patton J, et al. Soluble signals and insoluble substrata: novel molecular cues instructing the induction of bone. In: Massaro EJ, Rogers JM, editors. The skeleton. New York: Humana Press; 2004. pp. 217-27.
19. Sampath TK, Reddi AH. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci USA. 1981; 78: 7599-603.
20. Sampath TK, Reddi AH. Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc Natl Acad Sci USA. 1983; 80: 6591-5.
21. Khouri RK, Koudsi B, Reddi H. Tissue transformation into bone in vivo. A potential practical application. JAMA. 1991; 266: 1953-5.
22. Ripamonti U. Biomimetism, biomimetic matrices and the induction of bone formation. J Cell Mol Med. 2009; 13: 2953-72.
23. Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994; 55: 273-86.
24. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995; 332: 305-11.
25. Ripamonti U, Roden LC, Renton LF. Osteoinductive hydroxyapatite-coated titanium implants. Biomaterials. 2012; 33: 3813-23.
26. van Eeden SP, Ripamonti U. Bone differentiation in porous hydroxyapatite in baboons is regulated by the geometry of the substratum: implications for reconstructive craniofacial surgery. Plast Reconstr Surg. 1994; 93: 959-66.
27. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials. 1996; 17: 31-5.
28. Ripamonti U, Crooks J, Khoali L, et al. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs. Biomaterials. 2009; 30: 1428-39.
29. Ripamonti U, Klar RM, Renton LF, et al. Synergistic induction of bone formation by hOP-1, hTGF-β, and inhibition by zoledronate in macroporous coral-derived hydroxyapatites. Biomaterials. 2010; 31: 6400-10.
30. Shors EC. Coralline bone graft substitutes. Orthop Clin North Am. 1999; 30: 599-613.
31. Kanatani M, Sugimoto T, Fukase M, et al. Effect of elevated extracellular calcium on the proliferation of osteoblastic MC3T3-E1 cells: its direct and indirect effects via human monocytes. Biochem Biophys Res Commun. 1991; 181: 1425-30.
32. Kohn EC, Alessandro R, Spoonster J, et al. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA. 1995; 92: 1307-11.
33. Matsuoka H, Akiyama H, Okada Y, et al. In vitro analysis of the stimulation of bone formation by highly bioactive apatite- and wollastonite-containing glass-ceramic: released calcium ions promote osteogenic differentiation in osteoblastic ROS17/2.8 cells. J Biomed Mater Res. 1999; 47: 176-88.
34. Munaron L. Intracellular calcium, endothelial cells and angiogenesis. Recent Pat Anticancer Drug Discov. 2006; 1: 105-19.
35. Wu Q, Shao H, Eton D, et al. Extracellular calcium increases CXCR4 expression on bone marrow-derived cells and enhances pro-angiogenesis therapy. J Cell Mol Med. 2009; 13: 1-10.
36. Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J Cell Biochem. 2006; 97: 56-70.
37. Schnitzler CM, Ripamonti U, Mesquita JM. Histomorphometry of iliac crest trabecular bone in adult male baboons in captivity. Calcif Tissue Int. 1993; 52: 447-54.
38. Public Service Department. National code for animal use in research education, diagnosis and testing of drugs and related substances in South Africa. Pretoria, South Africa: Public Service Department; 1990.
39. McNamara LE, McMurray RJ, Biggs MJ, et al. Nanotopographical control of stem cell differentiation. J Tissue Eng. 2010; 1: 1-13.
40. Gittens RA, McLachlan T, Oliveres-Navarrete R, et al. The effect of combined micron-/submicron-scale surface roughness and nanoscale features on cell proliferation and differentiation. Biomaterials. 2011; 32: 3395-403.
41. Wilkinson A, Hewitt RN, McNamara LE, et al. Biomimetic microtopography to enhance osteogenesis in vitro. Acta Biomater. 2011; 7: 2919-25.
42. 2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneous diabetic Goto-Kahizaki rats. Atherosclerosis. 1997; 2: 167-75.
43. Ripamonti U, Ferretti C, Heliotis M. Soluble and insoluble signals and the induction of bone formation: molecular therapeutics recapitulating development. J Anat. 2006; 209: 447-68.
44. Trueta J. The role of the vessels in osteogenesis. J Bone Joint Surg. 1963; 45: 402-18.
45. Vlodavsky I, Folkman J, Sullivan R, et al. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA. 1987; 84: 2292-6.
46. Folkman J, Klagsbrun M, Sasse J, et al. A heparin binding angiogenic protein basic fibroblast growth factor-is stored within basement membranes. Am J Pathol. 1988; 130: 393-400.
47. Paralkar VM, Vukicevic S, Reddi AH. Transforming growth factor β type 1 binds to collagen type IV of basement membrane matrix: implications for development. Dev Biol. 1991; 143: 303-9.
48. Paralkar VM, Nandedkar AKN, Pointer RH, et al. Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem. 1990; 265: 17281-4.
49. Vukicevic S, Latin V, Chen P, et al. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem Biophys Res Commun. 1994; 198: 693-700.
50. Ripamonti U. Soluble osteogenic molecular signals and the induction of bone formation. Biomaterials. 2006; 27: 807-22.
51. Vukicevic S, Luyten FP, Kleinman HK, et al. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell. 1990; 63: 437-45.
52. Kneser U, Polykandriotis E, Ohnolz J, et al. Engineering of vascularized transplantable bone tissue: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006; 12: 1721-31.
53. Polykandriotis E, Arkudas A, Beier JP, et al. Intrinsic axial vascularization of an osteoconductive bone matrix by means of an arteriovenous vascular bundle. Plast Reconstr Surg. 2007; 120: 855-68.
54. Beier JP, Horch RE, Hess A, et al. Axial vascularization of a large volume calcium phosphate ceramic bone substitute in the sheep AV loop model. J Tissue Eng Regen Med. 2010; 4: 216-23.
55. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrata. Science. 2005; 310: 1139-43.
56. Dalby MJ, Gadegaard N, Tare R, et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater. 2007; 6: 997-1003.
57. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009; 324: 1673-7.
58. Ohgushi H, Dohi Y, Tamai S, et al. Osteogenic differentiation of marrow stromal stem cells in porous hydroxyapatite ceramics. J Biomed Mater Res. 1993; 27: 1401-7.
59. Hall BK, Miyake T. All for one and one for all: condensations and the initiation of skeletal development. BioEssays. 2000; 22: 138-47.
60. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 1996; 96: 599-606.
61. Barbado H, Fablet K, Ronjat M, et al. Gene regulation by voltage-dependant calcium channels. Biochem Biophys Acta. 2009; 1793: 1096-104.
62. Li H, Chang J. Stimulation of proangiogenesis by calcium silicate bioactive ceramic. Acta Biomater. 2012; 12: 1742-61.
63. Wei C, Wang X, Zheng M, et al. Calcium gradients underlying cell migration. Curr Opin Cell Biol. 2012; 2: 254-61.
64. Gray C, Boyde A, Jones SJ. Topographically induced bone formation in vitro: implication for bone implants and bone grafts. Bone. 1996; 2: 115-23.
65. Wieland M, Textor M, Spenor ND, et al. Wavelength-dependant roughness: a quantitative approach to characterising the topography of rough titanium surfaces. Int J Oral Maxillofac Implants. 2001; 2: 163-81.
66. Chou L, Firth JD, Uitto VJ, et al. Substratum surface topography allows cell shape and regulates fibronectin mRNA levels, mRNA stability, secretion and assembly in human fibroblasts. J Cell Sci. 1995; 4: 1563-73.
67. Curran JM, Chen R, Hunt JA. The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to cell substrate. Biomaterials. 2006; 27: 4783-93.
68. Reddi AH. Bone morphogenesis and modelling: soluble signals sculpt osteosomes in the solid state. Cell. 1997; 89: 159-61.
69. Parfitt AM, Mundy GR, Roodman GD, et al. A new model for the regulation of bone with the particular reference to the effect of bisphosphonates. J Bone Miner Res. 1996; 11: 150-9.
70. Sabokbar A, Panddey R, Díaz J, et al. Hydroxyapatite particles are capable of inducing osteoclast formation. J Mater Sci Mater Med. 2001; 12: 659-64.
71. Detsch R, Mayr H, Ziegler G. Formation of osteoclast-like cells on HA and TCP ceramics. Acta Biomater. 2008; 4: 139-48.
72. Le Nihouannen D, Daculsi G, Saffarzadeh A, et al. Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone. 2005; 36: 1086-93.
73. Ripamonti U. Bone induction by recombinant human osteogenic protein-1 (hOP-1, BMP-7) in the primate Papio ursinus with expression of mRNA of gene products of the TGF-β superfamily. J Cell Mol Med. 2005; 4: 911-28.